Literature DB >> 21828345

IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells.

Jan Novak1, Leona Raskova Kafkova, Hitoshi Suzuki, Milan Tomana, Karel Matousovic, Rhubell Brown, Stacy Hall, John T Sanders, T Matthew Eison, Zina Moldoveanu, Lea Novak, Zdenek Novak, Richard Mayne, Bruce A Julian, Jiri Mestecky, Robert J Wyatt.   

Abstract

BACKGROUND: Circulating immune complexes (CIC) containing galactose (Gal)-deficient IgA1 from adults with IgA nephropathy (IgAN) induce proliferation of cultured mesangial cells, but activities of CIC from pediatric patients with the disease have not been studied.
METHODS: CIC of different sizes were isolated from sera of pediatric and adult IgAN patients and their effects on cultured human mesangial cells (MC) were assessed by measuring cellular proliferation, expression of IL-6 and IL-8 and laminin and phosphotyrosine signaling.
RESULTS: Large CIC from pediatric IgAN patients (>800 kDa) containing Gal-deficient IgA1 stimulated cellular proliferation, whereas in some patients, smaller CIC were inhibitory. Addition of stimulatory and inhibitory CIC to MC differentially altered phosphorylation patterns of three major tyrosine-phosphorylated proteins of molecular mass 37, 60 and 115 kDa. The stimulatory CIC transiently increased tyrosine-phosphorylation of the 37-kDa protein and decreased phosphorylation of the other two proteins, whereas the inhibitory CIC increased phosphorylation of all three proteins. Furthermore, we investigated the influence of IgA1-containing CIC from sera of children with IgAN with clinically active disease (i.e., abnormal urinalysis and/or serum creatinine concentration) or inactive disease (i.e., normal urinalysis and serum creatinine concentration) on the expression of IL-6 and IL-8 genes by mesangial cells. Real-time reverse transcription-polymerase chain reaction results showed that the CIC from a patient with active disease stimulated MC to express the two cytokine genes at higher levels than did the CIC from a patient with inactive disease. Moreover, stimulatory CIC increased production of the extracellular matrix protein laminin.
CONCLUSION: These data indicate that sera of pediatric IgAN patients contain biologically active CIC with Gal-deficient IgA1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21828345      PMCID: PMC3203630          DOI: 10.1093/ndt/gfr448

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  38 in total

Review 1.  Progress in molecular and genetic studies of IgA nephropathy.

Authors:  J Novak; B A Julian; M Tomana; J Mesteck
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

2.  Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients.

Authors:  A C Allen; E M Bailey; P E Brenchley; K S Buck; J Barratt; J Feehally
Journal:  Kidney Int       Date:  2001-09       Impact factor: 10.612

3.  A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.

Authors:  G J Schwartz; G B Haycock; C M Edelmann; A Spitzer
Journal:  Pediatrics       Date:  1976-08       Impact factor: 7.124

4.  Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.

Authors:  Y Hiki; H Odani; M Takahashi; Y Yasuda; A Nishimoto; H Iwase; T Shinzato; Y Kobayashi; K Maeda
Journal:  Kidney Int       Date:  2001-03       Impact factor: 10.612

5.  [Intercapillary deposits of IgA-IgG].

Authors:  J Berger; N Hinglais
Journal:  J Urol Nephrol (Paris)       Date:  1968-09

6.  Humoral immunity against the proline-rich peptide epitope of the IgA1 hinge region in IgA nephropathy.

Authors:  T Kokubo; K Hashizume; H Iwase; K Arai; A Tanaka; K Toma; K Hotta; Y Kobayashi
Journal:  Nephrol Dial Transplant       Date:  2000-01       Impact factor: 5.992

Review 7.  Aberrant glycosylation in IgA nephropathy (IgAN).

Authors:  Rosanna Coppo; Alessandro Amore
Journal:  Kidney Int       Date:  2004-05       Impact factor: 10.612

8.  Aberrantly glycosylated IgA1 induces mesangial cells to produce platelet-activating factor that mediates nephrin loss in cultured podocytes.

Authors:  Rosanna Coppo; Valentina Fonsato; Sabrina Balegno; Emanuela Ricotti; Elisa Loiacono; Roberta Camilla; Licia Peruzzi; Alessandro Amore; Benedetta Bussolati; Giovanni Camussi
Journal:  Kidney Int       Date:  2009-12-16       Impact factor: 10.612

Review 9.  IgA nephropathy: an update.

Authors:  Bruce A Julian; Jan Novak
Journal:  Curr Opin Nephrol Hypertens       Date:  2004-03       Impact factor: 2.894

10.  Interactions of human mesangial cells with IgA and IgA-containing immune complexes.

Authors:  Jan Novak; Huong L Vu; Lea Novak; Bruce A Julian; Jiri Mestecky; Milan Tomana
Journal:  Kidney Int       Date:  2002-08       Impact factor: 10.612

View more
  36 in total

1.  The combined role of galactose-deficient IgA1 and streptococcal IgA-binding M Protein in inducing IL-6 and C3 secretion from human mesangial cells: implications for IgA nephropathy.

Authors:  Roland Schmitt; Anne-Lie Ståhl; Anders I Olin; Ann-Charlotte Kristoffersson; Johan Rebetz; Jan Novak; Gunnar Lindahl; Diana Karpman
Journal:  J Immunol       Date:  2014-05-21       Impact factor: 5.422

Review 2.  Immunoglobulin A nephropathy: a pathophysiology view.

Authors:  Rafaela Cabral Gonçalves Fabiano; Sérgio Veloso Brant Pinheiro; Ana Cristina Simões E Silva
Journal:  Inflamm Res       Date:  2016-06-28       Impact factor: 4.575

Review 3.  Glycosylation of IgA1 and pathogenesis of IgA nephropathy.

Authors:  Jan Novak; Bruce A Julian; Jiri Mestecky; Matthew B Renfrow
Journal:  Semin Immunopathol       Date:  2012-03-21       Impact factor: 9.623

4.  In vitro-generated immune complexes containing galactose-deficient IgA1 stimulate proliferation of mesangial cells.

Authors:  Takeshi Yanagihara; Rhubell Brown; Stacy Hall; Zina Moldoveanu; Alice Goepfert; Milan Tomana; Bruce A Julian; Jiri Mestecky; Jan Novak
Journal:  Results Immunol       Date:  2012-01-01

5.  Update on immunoglobulin A nephropathy, Part I: Pathophysiology.

Authors:  Maurizio Salvadori; Giuseppina Rosso
Journal:  World J Nephrol       Date:  2015-09-06

6.  Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy.

Authors:  Francois Berthoux; Hitoshi Suzuki; Lise Thibaudin; Hiroyuki Yanagawa; Nicolas Maillard; Christophe Mariat; Yasuhiko Tomino; Bruce A Julian; Jan Novak
Journal:  J Am Soc Nephrol       Date:  2012-08-16       Impact factor: 10.121

Review 7.  IgA nephropathy enigma.

Authors:  Jiri Mestecky; Jan Novak; Zina Moldoveanu; Milan Raska
Journal:  Clin Immunol       Date:  2016-07-18       Impact factor: 3.969

Review 8.  Markers for the progression of IgA nephropathy.

Authors:  Dita Maixnerova; Colin Reily; Qi Bian; Michaela Neprasova; Jan Novak; Vladimir Tesar
Journal:  J Nephrol       Date:  2016-05-03       Impact factor: 3.902

Review 9.  Henoch-Schönlein purpura nephritis.

Authors:  Martin Pohl
Journal:  Pediatr Nephrol       Date:  2014-04-15       Impact factor: 3.714

10.  TREM-1 Contributes to Inflammation in IgA Nephropathy.

Authors:  Yan-Feng Zhao; Li Zhu; Li-Jun Liu; Su-Fang Shi; Ji-Cheng Lv; Hong Zhang
Journal:  Kidney Dis (Basel)       Date:  2018-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.